Last reviewed · How we verify

NCT03491475

Echocardiography During Ajmaline Test

Status unknown Last updated 9 April 2018
What this trial tests

trial testing Ajmaline test in Brugada Syndrome in 100 participants. Status unknown.

Timeline
26 March 2018
Primary endpoint
31 March 2019
31 May 2019

Quick facts

Lead sponsorUniversitair Ziekenhuis Brussel
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date26 March 2018
Primary completion31 March 2019
Estimated completion31 May 2019
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

Adults 18 to 70, any sex, with Brugada Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study the investigators analyse echocardiographic images before and during Ajmaline test. The purpose is to know if any echocardiographic modifications are present during either negative or positive Ajmaline testing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Brugada Syndrome

Currently open trials in the same condition.

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing